FNDC5 and osteoporosis: The robust anti-inflammatory potential of irisin, especially via its ability to reduce NF-κB levels via AMPK phosphorylation, further supports the idea that the potentiation of irisin signaling may have beneficial effects as an adjuvant therapy against osteoporosis.